Pharmacopsychiatry 2007; 40(1): 43-44
DOI: 10.1055/s-2006-958522
Letter

© Georg Thieme Verlag KG Stuttgart · New York

Abuse, Dependency and Withdrawal with Gabapentin: A First Case Report

C. Victorri-Vigneau 1 , M. Guerlais 1 , P. Jolliet 1
  • 1Center for Evaluation and Information on Pharmacodependency, Clinical Pharmacology Department, Nantes University Hospital, Nantes, France
Further Information

Publication History

received 14. 2. 2006 revised 29. 9. 2006

accepted 10. 10. 2006

Publication Date:
27 February 2007 (online)

Introduction

Gabapentin has not been documented to produce dependency. This is the first case recorded in our institution of a patient having developed dependency while being treated with a high dose of gabapentin.

References

  • 1 Bonnet U, Banger M, Leweke FM, Specka M, Muller BW, Hashemi T. et al . Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial.  J Clin Psychopharmacol. 2003;  23 514-519
  • 2 Freye E, Levy JV, Partecke L. Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD) correlation with neurophysiological parameters.  Neurophysiol Clin. 2004;  34 81-89
  • 3 Haney M, Hart C, Collins ED, Foltin RW. Smoked cocaine discrimination in humans: effects of gabapentin.  Drug Alcohol Depend. 2005;  80 53-61
  • 4 Kumar P, Jain MK. Gabapentin in the management of pentazocine dependency: a potent analgesic anticraving agent.  J Assoc Physicians India. 2003;  51 673-676
  • 5 Markowitz JS, Finkenbine R, Myrick H, King L, Carson WH. Gabapentin abuse in a cocaine user: implications for treatment?.  J Clin Psychopharmacol. 1997;  17 423-424
  • 6 Martinez-Raga J, Sabater A, Perez-Galvez B, Castellano M, Cervera G. Add-on gabapentin in the treatment of opiate withdrawal.  Prog Neuropsychopharmacol Biol Psychiatry. 2004;  28 599-601
  • 7 Norton JW. Gabapentin withdrawal syndrome.  Clin Neuropharmacol. 2001;  24 245-246
  • 8 Olson WL, Gruenthal M, Mueller ME, Olson MD. Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.  Am J Med. 1997;  102 60-66
  • 9 Raby WN, Coomaraswamy S. Gabapentin reduces cocaine use among addicts from a community clinic sample.  J Clin Psychiatry. 2004;  65 84-86
  • 10 Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal.  Drugs Today (Barc). 2004;  40 603-619

Correspondence

C. Victorri-Vigneau

Centre d' Evaluation et d' Information sur la Pharmacodependance·Laboratoire de Pharmacologie

9 quai Moncousu

44093 Nantes cedex 1

France

Phone: + 33/2/400/840 96

Email: Caroline.vigneau@chu-nantes.fr

    >